Loading...

Haleon plc

HLNCFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$4.75
$-0.10(-2.06%)
U.S. Market opens in 14h 18m

Haleon plc Fundamental Analysis

Haleon plc (HLNCF) shows weak financial fundamentals with a PE ratio of 30.57, profit margin of 12.59%, and ROE of 6.43%. The company generates $8.1B in annual revenue with weak year-over-year growth of -0.61%.

Key Strengths

No significant strengths identified.

Areas of Concern

ROE6.43%
Cash Position3.08%
PEG Ratio6.64
Current Ratio0.92
We analyze HLNCF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 34.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
34.8/100

We analyze HLNCF's fundamental strength across five key dimensions:

Efficiency Score

Weak

HLNCF struggles to generate sufficient returns from assets.

ROA > 10%
3.18%

Valuation Score

Weak

HLNCF trades at a premium to fair value.

PE < 25
30.57
PEG Ratio < 2
6.64

Growth Score

Moderate

HLNCF shows steady but slowing expansion.

Revenue Growth > 5%
-0.61%
EPS Growth > 10%
45.45%

Financial Health Score

Moderate

HLNCF shows balanced financial health with some risks.

Debt/Equity < 1
0.52
Current Ratio > 1
0.92

Profitability Score

Weak

HLNCF struggles to sustain strong margins.

ROE > 15%
6.43%
Net Margin ≥ 15%
12.59%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is HLNCF Expensive or Cheap?

P/E Ratio

HLNCF trades at 30.57 times earnings. This suggests a premium valuation.

30.57

PEG Ratio

When adjusting for growth, HLNCF's PEG of 6.64 indicates potential overvaluation.

6.64

Price to Book

The market values Haleon plc at 1.93 times its book value. This may indicate undervaluation.

1.93

EV/EBITDA

Enterprise value stands at 13.00 times EBITDA. This signals the market has high growth expectations.

13.00

How Well Does HLNCF Make Money?

Net Profit Margin

For every $100 in sales, Haleon plc keeps $12.59 as profit after all expenses.

12.59%

Operating Margin

Core operations generate 18.85 in profit for every $100 in revenue, before interest and taxes.

18.85%

ROE

Management delivers $6.43 in profit for every $100 of shareholder equity.

6.43%

ROA

Haleon plc generates $3.18 in profit for every $100 in assets, demonstrating efficient asset deployment.

3.18%

Following the Money - Real Cash Generation

Operating Cash Flow

Haleon plc produces operating cash flow of $1.01B, showing steady but balanced cash generation.

$1.01B

Free Cash Flow

Haleon plc generates strong free cash flow of $916.36M, providing ample flexibility for dividends, buybacks, or growth.

$916.36M

FCF Per Share

Each share generates $0.10 in free cash annually.

$0.10

FCF Yield

HLNCF converts 2.98% of its market value into free cash.

2.98%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

30.57

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

6.64

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.93

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.79

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.52

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.92

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.06

vs 25 benchmark

ROA

Return on assets percentage

0.03

vs 25 benchmark

ROCE

Return on capital employed

0.06

vs 25 benchmark

How HLNCF Stacks Against Its Sector Peers

MetricHLNCF ValueSector AveragePerformance
P/E Ratio30.5729.02 Neutral
ROE6.43%745.00% Weak
Net Margin12.59%-46183.00% (disorted) Strong
Debt/Equity0.520.35 Weak (High Leverage)
Current Ratio0.924.52 Weak Liquidity
ROA3.18%-17797.00% (disorted) Weak

HLNCF outperforms its industry in 1 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Haleon plc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

34.03%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

122.76%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

196.21%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ